Pages that link to "Q24658203"
Jump to navigation
Jump to search
The following pages link to Binding of rasagiline-related inhibitors to human monoamine oxidases: a kinetic and crystallographic analysis (Q24658203):
Displaying 35 items.
- Time-dependent slowly-reversible inhibition of monoamine oxidase A by N-substituted 1,2,3,6-tetrahydropyridines (Q23923841) (← links)
- Structural Basis for the Inactivation of Thermus thermophilus Proline Dehydrogenase by N- Propargylglycine † , ‡ (Q27650407) (← links)
- Complexes of the copper-containing amine oxidase fromArthrobacter globiformiswith the inhibitors benzylhydrazine and tranylcypromine (Q27651059) (← links)
- The ‘gating’ residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition (Q27674763) (← links)
- Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology (Q28069609) (← links)
- Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases (Q28475810) (← links)
- Why p-OMe- and p-Cl-β-Methylphenethylamines Display Distinct Activities upon MAO-B Binding (Q28551848) (← links)
- Irreversible inactivation of snake venom l-amino acid oxidase by covalent modification during catalysis of l-propargylglycine (Q34774694) (← links)
- Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: insights from molecular modeling studies. (Q35942579) (← links)
- Discovery and characterization of a putrescine oxidase from Rhodococcus erythropolis NCIMB 11540. (Q36460019) (← links)
- Mechanistic analysis of a suicide inactivator of histone demethylase LSD1 (Q36866040) (← links)
- Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease (Q37578490) (← links)
- Explaining ADAGIO: a critical review of the biological basis for the clinical effects of rasagiline (Q37939755) (← links)
- Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms (Q38112214) (← links)
- Monoamine oxidase A and B substrates: probing the pathway for drug development (Q38217505) (← links)
- Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression (Q38325601) (← links)
- Searching for Multi-Targeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif. (Q38784489) (← links)
- An Overview of Analytical Methods for the Determination of Monoamine Oxidase Inhibitors in Pharmaceutical Formulations and Biological Fluids. (Q38974856) (← links)
- Rasagiline prevents apoptosis induced by PK11195, a ligand of the outer membrane translocator protein (18 kDa), in SH-SY5Y cells through suppression of cytochrome c release from mitochondria (Q39150864) (← links)
- Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase (Q39446623) (← links)
- Does 1-(R)-aminoindan Possess Neuroprotective Properties Against Experimental Parkinson's Disease? (Q39648372) (← links)
- A validated normal phase LC method for enantiomeric separation of rasagiline mesylate and its (S)-enantiomer on cellulose derivative-based chiral stationary phase (Q45130055) (← links)
- Liquid chromatographic resolution of racemic rasagiline and its analogues on a chiral stationary phase based on (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid (Q45772751) (← links)
- MAO inhibitors and their wider applications: a patent review (Q47658356) (← links)
- What a Difference a Methyl Group Makes: The Selectivity of Monoamine Oxidase B Towards Histamine and N-Methylhistamine (Q48000487) (← links)
- Indanones as high-potency reversible inhibitors of monoamine oxidase (Q48087297) (← links)
- Quantum-chemical approach to determining the high potency of clorgyline as an irreversible acetylenic monoamine oxidase inhibitor (Q48491402) (← links)
- Bio-analytical method development and validation of Rasagiline by high performance liquid chromatography tandem mass spectrometry detection and its application to pharmacokinetic study (Q49163672) (← links)
- Recognition dynamics of dopamine to human Monoamine oxidase B: role of Leu171/Gln206 and conserved water molecules in the active site cavity. (Q53320936) (← links)
- Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase. (Q54107922) (← links)
- How are Biogenic Amines Metabolized by Monoamine Oxidases? (Q58119904) (← links)
- Irreversible Inhibition of Monoamine Oxidase B by the Antiparkinsonian Medicines Rasagiline and Selegiline: A Computational Study (Q58119914) (← links)
- Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data? (Q88518698) (← links)
- Targeting Mitochondrial Proline Dehydrogenase with a Suicide Inhibitor to Exploit Synthetic Lethal Interactions with p53 Upregulation and Glutaminase Inhibition (Q92689130) (← links)
- Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes (Q97905937) (← links)